Pfizer Inc. and Eli Lilly and Company are pleased to announce the call for proposals for the 3rd Global Awards for Advancing Chronic Pain Research (ADVANCE), an independently-reviewed, competitive grants program. The Global Awards for Advancing Chronic Pain Research has been launched on the 4th of August. Proposals will be reviewed by an external multidisciplinary, Independent Review Committee comprising renowned, global experts in chronic pain. Proposals will be reviewed based on area of interest, originality, scientific merit, and feasibility. A total of US $1,000,000 will be available to fund approximately 5 individual research proposals of between US $50,000 and US $200,000.
Application deadline: September 15, 2020 (by 11:59 pm Eastern Daylight Time in the United States).
For more information about ADVANCE, including how to apply, please visit the website here.